Risk stratification of medulloblastoma: a paradigm for future childhood brain tumor management strategies (Q39810223)

14 September 2017

Risk stratification of medulloblastoma: a paradigm for future childhood brain tumor management strategies (English)

1 reference

14 September 2017

0 references

childhood brain tumor

1 reference

Roger J Packer

1

1 reference

14 September 2017

1 April 2011

1 reference

Current Neurology and Neuroscience Reports

14 September 2017

1 reference

14 September 2017

11

1 reference

14 September 2017

124-126

1 reference

14 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s11910-010-0168-5

14 September 2017

0 references

cites work

Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.

1 reference

https://api.crossref.org/works/10.1007%2FS11910-010-0168-5

Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-010-0168-5

Medulloblastoma: clinical and biologic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-010-0168-5

Treatment of early childhood medulloblastoma by postoperative chemotherapy alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-010-0168-5

Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-010-0168-5

Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-010-0168-5

Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-010-0168-5

Prediction of central nervous system embryonal tumour outcome based on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-010-0168-5

Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21128022

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11910-010-0168-5

1 reference

14 September 2017

1 reference

PubMed ID

21128022